The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 5.

Frishman, William H

Frishman, William H.

Frishman WH; Department of Cardiology and Medicine, New York Medical College, Westchester Health Care System, Valhalla, NY, William.Frishman@wmchealth.org.

Cardiol Rev ; 29(3): 109, 2021.

Article in English | MEDLINE | ID: covidwho-1147522

Subject(s)

Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/therapeutic use; Alanine/analogs & derivatives; Alanine/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Azetidines/therapeutic use; COVID-19/complications; COVID-19/prevention & control; COVID-19 Vaccines/therapeutic use; Dexamethasone/therapeutic use; Drug Combinations; Glucocorticoids/therapeutic use; Humans; Janus Kinase Inhibitors/therapeutic use; Purines/therapeutic use; Pyrazoles/therapeutic use; SARS-CoV-2; Sulfonamides/therapeutic use; Post-Acute COVID-19 Syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Cardiol Rev Journal subject: Vascular Diseases / Cardiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google